284 related articles for article (PubMed ID: 25012430)
1. Comparison of inflammatory cytokine levels among type I/type II and manic/hypomanic/euthymic/depressive states of bipolar disorder.
Bai YM; Su TP; Tsai SJ; Wen-Fei C; Li CT; Pei-Chi T; Mu-Hong C
J Affect Disord; 2014 Sep; 166():187-92. PubMed ID: 25012430
[TBL] [Abstract][Full Text] [Related]
2. Comparison of pro-inflammatory cytokines among patients with bipolar disorder and unipolar depression and normal controls.
Bai YM; Su TP; Li CT; Tsai SJ; Chen MH; Tu PC; Chiou WF
Bipolar Disord; 2015 May; 17(3):269-77. PubMed ID: 25257835
[TBL] [Abstract][Full Text] [Related]
3. Persistent inflammation and its relationship to leptin and insulin in phases of bipolar disorder from acute depression to full remission.
Tsai SY; Chung KH; Huang SH; Chen PH; Lee HC; Kuo CJ
Bipolar Disord; 2014 Dec; 16(8):800-8. PubMed ID: 25130211
[TBL] [Abstract][Full Text] [Related]
4. Pro-inflammatory cytokine associated with somatic and pain symptoms in depression.
Bai YM; Chiou WF; Su TP; Li CT; Chen MH
J Affect Disord; 2014 Feb; 155():28-34. PubMed ID: 24176538
[TBL] [Abstract][Full Text] [Related]
5. Cytokines in bipolar disorder: a systematic review and meta-analysis.
Munkholm K; Vinberg M; Vedel Kessing L
J Affect Disord; 2013 Jan; 144(1-2):16-27. PubMed ID: 22749156
[TBL] [Abstract][Full Text] [Related]
6. Effects of symptomatic severity on elevation of plasma soluble interleukin-2 receptor in bipolar mania.
Tsai SY; Yang YY; Kuo CJ; Chen CC; Leu SJ
J Affect Disord; 2001 May; 64(2-3):185-93. PubMed ID: 11313085
[TBL] [Abstract][Full Text] [Related]
7. Associations of Serum Cytokine Receptor Levels with Melancholia, Staging of Illness, Depressive and Manic Phases, and Severity of Depression in Bipolar Disorder.
Siwek M; Sowa-Kućma M; Styczeń K; Misztak P; Nowak RJ; Szewczyk B; Dudek D; Rybakowski JK; Nowak G; Maes M
Mol Neurobiol; 2017 Oct; 54(8):5883-5893. PubMed ID: 27660275
[TBL] [Abstract][Full Text] [Related]
8. Plasma concentrations of soluble cytokine receptors in euthymic bipolar patients with and without subsyndromal symptoms.
Cetin T; Guloksuz S; Cetin EA; Gazioglu SB; Deniz G; Oral ET; van Os J
BMC Psychiatry; 2012 Sep; 12():158. PubMed ID: 23013558
[TBL] [Abstract][Full Text] [Related]
9. Cytokines, brain-derived neurotrophic factor and C-reactive protein in bipolar I disorder - Results from a prospective study.
Jacoby AS; Munkholm K; Vinberg M; Pedersen BK; Kessing LV
J Affect Disord; 2016 Jun; 197():167-74. PubMed ID: 26994434
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory markers and their relationships with leptin and insulin from acute mania to full remission in bipolar disorder.
Tsai SY; Chung KH; Wu JY; Kuo CJ; Lee HC; Huang SH
J Affect Disord; 2012 Jan; 136(1-2):110-116. PubMed ID: 21962564
[TBL] [Abstract][Full Text] [Related]
11. Inflammation associated with volume reduction in the gray matter and hippocampus of older patients with bipolar disorder.
Tsai SY; Gildengers AG; Hsu JL; Chung KH; Chen PH; Huang YJ
J Affect Disord; 2019 Feb; 244():60-66. PubMed ID: 30317016
[TBL] [Abstract][Full Text] [Related]
12. A comparison study of metabolic profiles, immunity, and brain gray matter volumes between patients with bipolar disorder and depressive disorder.
Bai YM; Chen MH; Hsu JW; Huang KL; Tu PC; Chang WC; Su TP; Li CT; Lin WC; Tsai SJ
J Neuroinflammation; 2020 Jan; 17(1):42. PubMed ID: 32000805
[TBL] [Abstract][Full Text] [Related]
13. Association of pro-inflammatory cytokines with clinical features in euthymic patients with Bipolar-I-Disorder.
Vares EA; Lehmann S; Sauer C; Pariante C; Wieland F; Soltmann B; Bauer M; Ritter P
J Affect Disord; 2020 Dec; 277():450-455. PubMed ID: 32871531
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment levels of sTNF-R1 and sIL-6R are associated with a higher vulnerability for IFN-alpha-induced depressive symptoms in patients with malignant melanoma.
Friebe A; Schwarz MJ; Schmid-Wendtner M; Volkenandt M; Schmidt F; Horn M; Janssen G; Schaefer M
J Immunother; 2007 Apr; 30(3):333-7. PubMed ID: 17414324
[TBL] [Abstract][Full Text] [Related]
15. Lipid Peroxidation and Immune Biomarkers Are Associated with Major Depression and Its Phenotypes, Including Treatment-Resistant Depression and Melancholia.
Sowa-Kućma M; Styczeń K; Siwek M; Misztak P; Nowak RJ; Dudek D; Rybakowski JK; Nowak G; Maes M
Neurotox Res; 2018 Feb; 33(2):448-460. PubMed ID: 29103192
[TBL] [Abstract][Full Text] [Related]
16. A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression.
Goldsmith DR; Rapaport MH; Miller BJ
Mol Psychiatry; 2016 Dec; 21(12):1696-1709. PubMed ID: 26903267
[TBL] [Abstract][Full Text] [Related]
17. Altered serum levels of TNF-α, IL-6 and IL-18 in manic, depressive, mixed state of bipolar disorder patients.
Luo Y; He H; Zhang M; Huang X; Fan N
Psychiatry Res; 2016 Oct; 244():19-23. PubMed ID: 27455146
[TBL] [Abstract][Full Text] [Related]
18. Elevated levels of IL-6 and IL-18 in manic and hypomanic states in rapid cycling bipolar disorder patients.
Munkholm K; Weikop P; Kessing LV; Vinberg M
Brain Behav Immun; 2015 Jan; 43():205-13. PubMed ID: 25451609
[TBL] [Abstract][Full Text] [Related]
19. Assessment of cytokine levels and hs-CRP in bipolar I disorder before and after treatment.
Uyanik V; Tuglu C; Gorgulu Y; Kunduracilar H; Uyanik MS
Psychiatry Res; 2015 Aug; 228(3):386-92. PubMed ID: 26160203
[TBL] [Abstract][Full Text] [Related]
20. Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor.
Hope S; Melle I; Aukrust P; Steen NE; Birkenaes AB; Lorentzen S; Agartz I; Ueland T; Andreassen OA
Bipolar Disord; 2009 Nov; 11(7):726-34. PubMed ID: 19839997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
